Furthermore, CFL1 is expressed more highly in portal vein tumor thrombus (pvtt) than in HCC tumor tissues, and an increase in CFL1 expression is closely related to adverse clinical features, making it an independent risk predictor for the overall survival of HCC patients. Here, CFL1 is linked to hepatocellular carcinoma.